Aptahem intends to apply for additional patents on new discoveries made, where it is considered appropriate to strengthen the company’s intellectual property protection. The company may also obtain licenses from external sources.
Aptahems main asset is a patent family shown in the table below. The company’s patent applications and granted patents are based on unique new chemical compounds. The compounds have a strong patent protection, that covers the unique RNA aptamers. Aptahems intellectual property strategy is to apply for patents in the countries deemed the most important markets for the establishment of the company. At present, this is Europe, USA, Canada, China and India.
|Region||Application number||Application date||Expiration date||Status|